Research Training in Pediatric Oncology

儿科肿瘤学研究培训

• 批准号: 9334113
• 负责人: SCOTT A ARMSTRONG
• 金额: $ 53.88万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-13 至 2019-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9334113
• 关键词: Pediatric Oncology; Research Training

DESCRIPTION (provided by applicant): This is a competitive renewal application for training grant support in pediatric oncology. The goal of this T32 program is to train physicians who will be the future academic leaders in basic and/or clinical pediatric oncology research and who will work to reduce the burden of cancer in the pediatric population. To accomplish this goal we have engaged a diverse and outstanding training faculty that embraces multiple areas of basic ("wet bench"), translational and clinical research. This experienced and highly accomplished group includes members of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute (DFCI), the Division of Pediatric Hematology/Oncology at Boston Children's Hospital (BCH), and additional components of the Harvard Medical School (HMS). Particular emphasis is placed on close mentorship of trainees in the selection of mentors and in on-going oversight during their research. The T32 program provides training in oncology research at the postdoctoral level for 8 trainees, selected from the combined DFCI-BCH pediatric hematology/oncology fellowship program, who are in their second, third and fourth years of training. The program is committed to identifying and supporting the most promising fellows, including minority candidates. Over the past 45 years the DFCI-BCH fellowship program has trained over 200 individuals, many of whom are leaders of academic pediatric hematology/oncology programs. Continued T32 support will ensure the training of investigational pediatric oncologists, whose research will contribute immeasurably to the understanding and management of childhood cancers.

描述（由申请人提供）：这是一份针对儿科肿瘤学培训补助金支持的竞争性续展申请。该 T32 计划的目标是培训医生，使他们成为基础和/或临床儿科肿瘤学研究的未来学术领导者，并致力于减轻儿科人群的癌症负担。为了实现这一目标，我们聘请了一支多元化、优秀的培训师资队伍，涵盖基础（“湿台”）、转化和临床研究等多个领域。这个经验丰富且成就斐然的团队包括达纳法伯癌症研究所 (DFCI) 儿科肿瘤科、波士顿儿童医院 (BCH) 儿科血液学/肿瘤科以及哈佛医学院 (HMS) 其他部门的成员。在导师的选择和研究过程中的持续监督方面，特别强调对受训者的密切指导。 T32 项目为 8 名受训人员提供博士后级别的肿瘤学研究培训，这些受训人员选自 DFCI-BCH 儿科血液学/肿瘤学联合奖学金项目，处于培训的第二年、第三年和第四年。该计划致力于识别和支持最有前途的研究员，包括少数族裔候选人。在过去 45 年中，DFCI-BCH 奖学金计划已培训了 200 多名人员，其中许多人是学术儿科血液学/肿瘤学项目的领导者。 T32 的持续支持将确保对研究性儿科肿瘤学家进行培训，他们的研究将为了解和管理儿童癌症做出不可估量的贡献。